In contrast, in relation to colorectal cancer [12,13,14,15] and different lymphoma subtypes [16,17,18,19,20,21,22], a higher quantity of FoxP3+ Tregs is linked to improved survival outcomes. This evidence concerns the gene FOXP3 and lymphoma.